|
 |
 |
Mar 1, 2008
By: John Jesitus
|
Early clinical research shows that fractional deep dermal ablation is safe and effective for severe photodamage including
rhytids, skin laxity and pigmentation problems, says a researcher involved with pivotal FDA trials. Mar 1, 2008
By: John Jesitus
|
A nonablative 1,550 nm erbium-doped fiber laser effectively treats facial and non-facial photodamage, rhytids and dyspigmentation
with a favorable side effect and recovery profile, according to a recent study. Mar 1, 2008
By: Cheryl Guttman
|
Results from a repeat treatment study highlight the persistence of the benefits provided by the family of smooth-gel hyaluronic
acid fillers (Juvéderm, Allergan) for correction of nasolabial folds. The retreatment was administered within 24 to
36 weeks after the last initial treatment. It required significantly less filler volume than originally, and after 24 weeks,
was associated with clinically significant improvement exceeding that achieved originally. Mar 1, 2008
By: Zoe Diana Draelos, M.D.
|
Zoe Diana Draelos, M.D. answers cosmetic questions about hair shine and sunscreen safety Mar 1, 2008
By: John Jesitus
|
State-of-the-art periorbital rejuvenation requires going beyond skin-tightening surgeries to address underlying structures
from a three-dimensional, volumetric standpoint, says an expert. Mar 1, 2008
By: John Jesitus
|
As the cosmeceuticals category explodes, dermatologists need to know how to dispense practical advice while keeping recommended
regimens simple, says an expert. Mar 1, 2008
By: Nancy A. Melville
|
Much about it is still somewhat of a mystery, but early findings on a topical form of botulinum toxin have been compelling
enough to earn a $20 million show of support from Medicis and catapult the research onto the cosmetic medicine radar. Mar 1, 2008
By: John Jesitus
|
Key developments in facial rejuvenation techniques that promote new collagen induction include the introduction of fractional
ablative lasers, as well as the advent of adjunctive treatments including LEDs, fillers and topical agents, an expert says. Mar 1, 2008
By: John Jesitus
|
A relatively new trolamine/sodium alginate emulsion has proven to be noncomedogenic, according to a small study.
|
|
